TW255886B - - Google Patents

Info

Publication number
TW255886B
TW255886B TW083103432A TW83103432A TW255886B TW 255886 B TW255886 B TW 255886B TW 083103432 A TW083103432 A TW 083103432A TW 83103432 A TW83103432 A TW 83103432A TW 255886 B TW255886 B TW 255886B
Authority
TW
Taiwan
Prior art keywords
compound
general formula
lower alkyl
cycloalkyl
alkyl
Prior art date
Application number
TW083103432A
Other languages
English (en)
Chinese (zh)
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of TW255886B publication Critical patent/TW255886B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
TW083103432A 1993-04-16 1994-04-18 TW255886B (show.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8994493 1993-04-16

Publications (1)

Publication Number Publication Date
TW255886B true TW255886B (show.php) 1995-09-01

Family

ID=13984820

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103432A TW255886B (show.php) 1993-04-16 1994-04-18

Country Status (13)

Country Link
US (1) US5488134A (show.php)
EP (1) EP0646570B1 (show.php)
JP (1) JP3411036B2 (show.php)
KR (1) KR100277242B1 (show.php)
CN (1) CN1046937C (show.php)
AT (1) ATE167662T1 (show.php)
AU (1) AU666819B2 (show.php)
CA (1) CA2138264C (show.php)
DE (1) DE69411243T2 (show.php)
DK (1) DK0646570T3 (show.php)
ES (1) ES2119190T3 (show.php)
TW (1) TW255886B (show.php)
WO (1) WO1994024087A1 (show.php)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121060C (en) * 1993-04-16 2004-04-06 Sachio Mori Preparation of lignan analogues
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
KR100376281B1 (ko) * 1995-12-26 2003-09-26 에스케이케미칼주식회사 리그난의 제조방법
DK1026167T3 (da) 1997-09-29 2003-05-26 Meiji Seika Kaisha Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
DK1140189T3 (da) 1998-12-23 2003-09-15 Searle Llc Kombinationer af ileal galdesyre-transportinhibitorer og fibrinsyrederivater til cardiovaskulære indikationer
AU3103800A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
AU2157500A (en) 1998-12-23 2000-07-31 G.D. Searle Llc Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
BR9916486A (pt) 1998-12-23 2002-02-05 Searle Llc Combinações de inibidores do transporte de ácidos biliares no ìleo e inibidores da proteìna de transferência do ester colesteril para indicações cardiovasculares
EA004877B1 (ru) 1998-12-23 2004-08-26 Джи.Ди.Сирл Ллс Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и агентов, секвестрирующих желчные кислоты, для сердечно-сосудистых показаний
US6458850B1 (en) 1998-12-23 2002-10-01 G.D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
EP1286984A2 (en) 2000-03-10 2003-03-05 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
WO2001068096A2 (en) * 2000-03-10 2001-09-20 Pharmacia Corporation Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
BR0213501A (pt) 2001-11-02 2004-08-24 Searle Llc Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato
MXPA04006255A (es) 2002-01-17 2004-09-27 Pharmacia Corp Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
EP4137137A1 (en) 2010-05-26 2023-02-22 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
JP6217938B2 (ja) 2011-10-28 2017-10-25 ルメナ ファーマシューティカルズ エルエルシー 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤
EA038594B1 (ru) 2011-10-28 2021-09-21 Шайр Хьюман Дженетик Терапис, Инк. Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
KR20160002773A (ko) 2013-03-15 2016-01-08 루메나 파마수티컬즈, 인코포레이티드 원발성 담관염 및 염증성 장 질환 치료용 담즙산 재순환 억제제
AU2014229050A1 (en) 2013-03-15 2015-10-22 Lumena Pharmaceuticals Llc Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease
EP4424363B1 (en) 2019-02-12 2026-04-29 Mirum Pharmaceuticals, Inc. Methods for increasing growth in pediatric subjects having cholestatic liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0372422A (ja) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd 抗脂血剤
JPH03157351A (ja) * 1989-11-13 1991-07-05 Tanabe Seiyaku Co Ltd ナフタレン誘導体及びその製法
ATE139990T1 (de) * 1991-10-17 1996-07-15 Shionogi & Co Lignan-analoge, ihre herstellung und hypolipidemische arzneimittel

Also Published As

Publication number Publication date
CN1046937C (zh) 1999-12-01
CA2138264A1 (en) 1994-10-27
CA2138264C (en) 2004-04-06
KR950701902A (ko) 1995-05-17
CN1109685A (zh) 1995-10-04
ES2119190T3 (es) 1998-10-01
EP0646570A1 (en) 1995-04-05
JP3411036B2 (ja) 2003-05-26
WO1994024087A1 (fr) 1994-10-27
DK0646570T3 (da) 1998-10-26
AU666819B2 (en) 1996-02-22
AU6437994A (en) 1994-11-08
ATE167662T1 (de) 1998-07-15
DE69411243T2 (de) 1998-11-19
EP0646570B1 (en) 1998-06-24
EP0646570A4 (en) 1995-08-09
KR100277242B1 (ko) 2001-02-01
DE69411243D1 (de) 1998-07-30
US5488134A (en) 1996-01-30

Similar Documents

Publication Publication Date Title
EP0646570A4 (en) PROCESS FOR PRODUCING A LIGNAN COMPOUND.
AU638747B2 (en) Improvements in or relating to organic compounds
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
TW223645B (show.php)
AU1120095A (en) Novel imidazole derivative and process for producing the same
EP0554455A4 (show.php)
AU2722095A (en) Novel pyrrolocarbazoles
GR3025599T3 (en) the same Carbazolone derivatives and process for preparing
DK92295A (da) Fremgangsmåde til fremstilling af 1,4-benzoquinoner
AU8460791A (en) Compound, preparation and use
EP0601191A4 (en) Novel tetracyclic compound.
AU2406097A (en) Process for the preparation of tetrahydro-indolizines
IL119331A0 (en) Method for preparing alpha, beta-unsaturated-beta-trifluoromethyl carboxylates and related compounds
GR3032474T3 (en) Selective dehalogenation method
AU8452591A (en) 2-thio-1-aminocarbonyl cyclo alk-1-enes
EP0331073A3 (en) Benzhydrylamine derivatives
GR3034291T3 (en) Catalyst with improved activity for ethylene (co)-polymerization
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
GR3004216T3 (show.php)
MX9800042A (es) Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias.
MX9800041A (es) Procedimiento mejorado para sintetizar intermediarios de carbapenem.
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
EP0657412A4 (show.php)
GR3021427T3 (en) Indole derivative
AU8762491A (en) Process for producing azacycloalkane derivative

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees